Literature DB >> 12405632

The mouse as a model for investigation of human granulocytic ehrlichiosis: current knowledge and future directions.

Dori L Borjesson1, Stephen W Barthold.   

Abstract

The use of laboratory mice to investigate correlates of infectious disease, including infection kinetics, cellular alterations, cytokine profiles, and immune response in the context of an intact host has expanded exponentially in the last decade. A marked increase in the availability of transgenic mice and research tools developed specifically for the mouse parallels and enhances this research. Human granulocytic ehrlichiosis (HGE) is an emerging, zoonotic disease caused by tick-borne bacteria. The HGE agent (Anaplasma phagocytophila) is one of two recognized pathogens to cause human granulocytic ehrlichiosis (HGE). The mouse model of HGE complements in vitro tissue culture studies, limited in vivo large animal studies, and ex vivo studies of human and ruminant neutrophils, and promises new avenues to approach mechanisms of disease. In the overview reported here, we focus principally on current research into HGE pathogenesis using the mouse model. Included is a discussion of current changes in ehrlichial classification and nomenclature, a review of ehrlichial biology and ecology, and highlights of clinical disease in animals and people.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12405632

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  11 in total

1.  Receptor interacting protein-2 contributes to host defense against Anaplasma phagocytophilum infection.

Authors:  Bindu Sukumaran; Yasunori Ogura; Joao H F Pedra; Koichi S Kobayashi; Richard A Flavell; Erol Fikrig
Journal:  FEMS Immunol Med Microbiol       Date:  2012-07-23

2.  Downregulation of CXCL12 signaling and altered hematopoietic stem and progenitor cell trafficking in a murine model of acute Anaplasma phagocytophilum infection.

Authors:  J L Johns; D L Borjesson
Journal:  Innate Immun       Date:  2011-09-29       Impact factor: 2.680

3.  Influence of Genetic Background on Hematologic and Histopathologic Alterations during Acute Granulocytic Anaplasmosis in 129/SvEv and C57BL/6J Mice Lacking Type I and Type II Interferon Signaling.

Authors:  Jennifer L Johns; Marielle L Discipulo; Amanda L Koehne; Kaitlin A Moorhead; Claude M Nagamine
Journal:  Comp Med       Date:  2017-03-01       Impact factor: 0.982

4.  CXCR2 blockade influences Anaplasma phagocytophilum propagation but not histopathology in the mouse model of human granulocytic anaplasmosis.

Authors:  Diana G Scorpio; Mustafa Akkoyunlu; Erol Fikrig; J Stephen Dumler
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

5.  Sequential analysis of Anaplasma phagocytophilum msp2 transcription in murine and equine models of human granulocytic anaplasmosis.

Authors:  Diana G Scorpio; Christian Leutenegger; Jeannine Berger; Nicole Barat; John E Madigan; J Stephen Dumler
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

6.  Anaplasma phagocytophilum in white-tailed deer.

Authors:  Robert F Massung; Joshua W Courtney; Shannon L Hiratzka; Virginia E Pitzer; Gary Smith; Richard L Dryden
Journal:  Emerg Infect Dis       Date:  2005-10       Impact factor: 6.883

7.  A hybrid protein containing MSP1a repeats and Omp7, Omp8 and Omp9 epitopes protect immunized BALB/c mice against anaplasmosis.

Authors:  Alex Sander R Cangussu; Luis André M Mariúba; Pritesh Lalwani; Keila Dayane E S Pereira; Spartaco Astolphi-Filho; Patricia P Orlandi; Sabrina Epiphanio; Kelvison F Viana; Mucio Flavio B Ribeiro; Hidelberto M Silva; Claudio R F Marinho; Paulo A Nogueira
Journal:  Vet Res       Date:  2018-01-19       Impact factor: 3.683

8.  Binding of Host Cell Surface Protein Disulfide Isomerase by Anaplasma phagocytophilum Asp14 Enables Pathogen Infection.

Authors:  Ryan S Green; Waheeda A Naimi; Lee D Oliver; Nathaniel O'Bier; Jaehyung Cho; Daniel H Conrad; Rebecca K Martin; Richard T Marconi; Jason A Carlyon
Journal:  mBio       Date:  2020-01-28       Impact factor: 7.786

9.  Differential Susceptibility of Male Versus Female Laboratory Mice to Anaplasma phagocytophilum Infection.

Authors:  Waheeda A Naimi; Ryan S Green; Chelsea L Cockburn; Jason A Carlyon
Journal:  Trop Med Infect Dis       Date:  2018-07-23

10.  An efficient microinjection method to generate human anaplasmosis agent Anaplasma phagocytophilum-infected ticks.

Authors:  Vikas Taank; Ellango Ramasamy; Hameeda Sultana; Girish Neelakanta
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.